Page last updated: 2024-08-05 11:09:35
naphtho-gamma-pyrone
Any naphthopyran whose skeleton consists of a naphathalene ring system ortho-fused to a gamma-pyrone.
ChEBI ID: 64542
Members (7)
Member | Definition | Role |
---|---|---|
adefovir | A dimeric naphthopyran with formula C32H26O10, originally isolated from Aspergillus niger. | aurasperone A |
alpha-naphthoflavone | An extended flavonoid resulting from the formal fusion of a benzene ring with the h side of flavone. A synthetic compound, it is an inhibitor of aromatase (EC 1.14.14.14). | alpha-naphthoflavone |
beta-naphthoflavone | An extended flavonoid resulting from the formal fusion of a benzene ring with the f side of flavone. | beta-naphthoflavone |
flavasperone | A naphtho-gamma-pyrone that is 4H-naphtho[1,2-b]pyran-4-one carrying a methyl substituent at position2, a hydroxy substituent at position 5 and two methoxy substotuents at positions 8 and 10. Originally isolated from Aspergillus niger. | flavasperone |
fonsecin | A naphtho-gamma-pyrone that is 2,3-dihydro-4H-benzo[g]chromen-4-one bearing a methyl substituent at position 2, a methoxy substituent at position 6 and three hydroxy substituents at positions 2, 5 and 8. | fonsecin |
fonsecinone a | A dimeric naphthopyran with formula C32H26O10, originally isolated from Aspergillus niger. | fonsecinone A |
rubrofusarin B | A benzochromenone that is rubrofusarin in which the hydroxy group at position 6 has been converted to the corresponding methyl ether. | rubrofusarin B |
Research
Studies (1,739)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 490 (28.18) | 18.7374 |
1990's | 516 (29.67) | 18.2507 |
2000's | 406 (23.35) | 29.6817 |
2010's | 268 (15.41) | 24.3611 |
2020's | 59 (3.39) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 1 (0.05%) | 5.53% |
Reviews | 20 (1.03%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 1,912 (98.91%) | 84.16% |